Medicines And Healthcare Products Regulatory Agency

Type: Organization
Name: Medicines And Healthcare Products Regulatory Agency
First reported Aug 29 2014 - Updated Aug 29 2014 - 1 reports

One Stroke every Five Minute -timing and safety

In the UK there is one person suffering a stroke Any sudden neurological problem caused by a bleed or a clot in a blood vessel. every five minutes. The perceived medical wisdom surrounding the effective treatment of this potentially fatal, if not highly ... [Published Total Health - Aug 29 2014]
First reported Aug 27 2014 - Updated Aug 27 2014 - 1 reports

MHRA launches stroke drug review

The Medicines and Healthcare products Regulatory Agency (MHRA), the UK medicines watchdog, is to review the safety of alteplase - a drug used to treat strokes.The MHRA believes the benefits of alteplase outweigh the risks but it is revisiting the evidence ... [Published Pharmacy Magazine - Aug 27 2014]
First reported Aug 26 2014 - Updated Aug 26 2014 - 1 reports

Radiograph detection difficulties may lead to underreported component size mismatch in hips

An analysis of metal-on-metal hips showed a 1% prevalence of component size mismatch, an event that may be underreported due to difficulties in intraoperative and plain radiograph detection, according to researchers.Through a review of 1,200 failed metal-on-metal ... [Published Orthopedics Today - Aug 26 2014]
First reported Aug 22 2014 - Updated Aug 23 2014 - 1 reports

Experts to review stroke clot-buster

The UK medicines watchdog is to review the safety of a clot-busting drug often used to treat strokes.The Medicines and Healthcare products Regulatory Agency believes the benefits of alteplase outweigh the risks.But it is revisiting the evidence. Some ... [Published BBC - Aug 22 2014]
First reported Aug 22 2014 - Updated Aug 22 2014 - 1 reports

UK MHRA approves Cbris Lifesciences’ new facility

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved Claris Lifesciences’ newly commissioned facility (Plant 2). ... [Published PBR - News - Aug 22 2014]
First reported Aug 21 2014 - Updated Aug 21 2014 - 1 reports

Chair appointment to the Advisory Board on the Registration of Homeopathic Products

Professor Angus Mackay has been appointed as Chair of the (ABRHP), with effect from 4 August 2014 for a period of four years.The appointment will involve a time commitment of approximately 6 meetings per year. Remuneration for the role will be at a rate ... [Published MHRA - Aug 21 2014]
First reported Aug 21 2014 - Updated Aug 21 2014 - 2 reports

Claris Lifesciences shares up 3.5% on BSE

MUMBAI: Shares of drug firm Claris Lifesciences today rose by over 3.5 per cent as the company has received approval by the UK health regulator, Medicines and Healthcare products Regulatory Agency (MHRA) for its newly commissioned plant in Ahmedabad.Stock ... [Published Economic Times - Aug 21 2014]
First reported Aug 21 2014 - Updated Aug 21 2014 - 1 reports

Insulin syringe medical device alert

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a medical device alert for 1ml insulin syringes manufactured by Medicina. The devices are unable to deliver less than 7 units of insulin and have not been properly evaluated for ... [Published Pharmaceutical Journal - Aug 21 2014]
First reported Aug 18 2014 - Updated Aug 19 2014 - 3 reports

Man jailed for peddling hyper-strength ‘herbal’ erection tablets

A man has been sentenced to 16 weeks in a UK prison for selling sham ‘Herbal Viagra’ tablets that contained dangerous levels of tadalafil and sibutramine, compounds that are banned in supplements.Xiao Ping Yan, 58, was sentenced at Wood Green Crown Court, ... [Published Nutra Ingredients - Aug 19 2014]
First reported Aug 14 2014 - Updated Aug 14 2014 - 1 reports

Idarubicin injection recalled

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 2 medicines recall for two batches of idarubicin (Teva) injection 1mg/ml 5ml and 10 ml. Further information is available on the MHRA website .Citation: The Pharmaceutical ... [Published Pharmaceutical Journal - Aug 14 2014]
First reported Aug 14 2014 - Updated Aug 14 2014 - 1 reports

An unhealthy situation

The recent report from the Institute of Mechanical Engineers entitled 'Biomedical engineering: advancing UK healthcare' makes a number of interesting points about the future role of engineers in medicine.Among the report's recommendations was the call ... [Published Eureka Magazine - Aug 14 2014]
First reported Aug 05 2014 - Updated Aug 06 2014 - 2 reports

Hundreds of patients recalled at a North hospital following problems with the cleaning of medical machines

North Cumbria University Hospitals NHS Trust has written to 357 patients affected by the discoveryHundreds of patients treated at a North hospital have been recalled following problems with the sterile cleaning of medical machines.North Cumbria University ... [Published The Journal - Aug 05 2014]

Quotes

"Furthermore, no adverse effects were seen during the course of the experiment, which comprised six weeks of continuous treatment at three differing dose levels" it said
The MHRA are setting up an expert working group "to ensure all relevant sources of evidence have been taken into consideration"
"My concerns using alteplase for stroke have always been that the risks of this drug are quite considerable, particularly with bleeding into the brain. The question is, do the benefits justify that risk? And I am not myself convinced that they do" he said. Dr Shinton added many stroke specialists shared his concerns
"In fact, exhaled aerosol is likely to increase above background levels the risk of disease to bystanders, especially in the case of some ENDS that produce toxicant levels in the range of that produced by some cigarettes."

More Content

All (83) | News (77) | Reports (0) | Blogs (5) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
VALIRX : Says Preclinical Trials For VAL401 In ... [Published 4 Traders - 21 hours ago]
The promise and challenges of e-cigarettes – th... [Published Cancer Research UK - Aug 29 2014]
One Stroke every Five Minute -timing and safety [Published Total Health - Aug 29 2014]
MHRA launches stroke drug review [Published Pharmacy Magazine - Aug 27 2014]
E-cigarettes: no indoor smoking ban planned in ... [Published Guardian.co.uk - Aug 26 2014]
Regulatory Professionals, Top Regulators From A... [Published Regulatory Affairs Professionals Society - Aug 26 2014]
Radiograph detection difficulties may lead to u... [Published Orthopedics Today - Aug 26 2014]
Medicine watchdog launches stroke drug review [Published OnMedicanet - Aug 26 2014]
Pioglitazone cardiac risk and risk of jaw osteo... [Published Pharmaceutical Journal - Aug 23 2014]
Experts Examine Regulation of Health-Related Mo... [Published Regulatory Affairs Professionals Society - Aug 22 2014]
Experts to review stroke clot-buster [Published BBC - Aug 22 2014]
UK MHRA approves Cbris Lifesciences’ new facility [Published PBR - News - Aug 22 2014]
Claris gets MHRA OK for injectables plant [Published In-Pharmatechnologist - Aug 21 2014]
Chair appointment to the Advisory Board on the ... [Published MHRA - Aug 21 2014]
Decision to control tramadol results from learn... [Published Pharmaceutical Journal - Aug 21 2014]
Claris Lifesciences shares up 3.5% on BSE [Published Economic Times - Aug 21 2014]
Cardiac arrest trial will test adrenaline again... [Published Pharmaceutical Journal - Aug 21 2014]
Insulin syringe medical device alert [Published Pharmaceutical Journal - Aug 21 2014]
Claris Lifesciences gets MHRA nod for new plant [Published Business Standard India - Aug 21 2014]
Claris Life up 6%, gets MHRA approval for Ahmed... [Published Moneycontrol.com - Aug 21 2014]
MHRA launches online oral anticoagulation module [Published PMLive - Aug 21 2014]
Hip replacements: what you need to know [Published Saga - Aug 19 2014]
BNF updates advice on dual blockade and ivabrad... [Published Pharmaceutical Journal - Aug 19 2014]
Man jailed for peddling hyper-strength ‘herbal’... [Published Nutra Ingredients - Aug 19 2014]
Man sentenced for supplying unlicensed erectile... [Published Pharmacy.Biz - Aug 18 2014]
Man jailed for selling super-strength 'herbal' ... [Published OnMedicanet - Aug 18 2014]
Shire Confirms Jobs Are Safe At Northumberland-... [Published BioSpace - Aug 15 2014]
Shire acquires assets of SCM Pharma [Published Manufacturing Chemist - Aug 15 2014]
SCM's woes part of UK-wide aseptic slowdown, sa... [Published In-Pharmatechnologist - Aug 15 2014]
Idarubicin injection recalled [Published Pharmaceutical Journal - Aug 14 2014]
1 2 3
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
UK MHRA approves Cbris Lifesciences’ new facility [Published PBR - News - Aug 22 2014]
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved Claris Lifesciences’ newly commissioned facility (Plant 2). ...
UK says Mylan recalls batches of Indian-made an... [Published Yahoo! Health News - Jun 18 2014]
U.S. drugmaker Mylan is recalling batches of the injectable antibiotic clarithromycin made in India due to possible impurities, Britain's healthcare regulator said on Wednesday. The Medicines and Healthcare products Regulatory Agency, or MHRA... ...
This week: Petards Fit for Growth, Galasys off ... [Published Proactiveinvestors United Kingdom website - Apr 03 2014]
BILL debt reduction,CCE award,CHRR trading update,ECK payment contracts,Galasys Intention to float on AIM,Haydale Graphene Industries Intention to float on AIM,PPT Pay in Your Currency,PEG final results,RAME Energy Intention to float on AIM,RENE UK regulatory ...
e-Therapeutics announces recruitment resumes in... [Published PBR - News - Mar 27 2014]
e-Therapeutics has announced that it has received approval from Medicines and Healthcare products Regulatory Agency (MHRA) to recommence recruitment of new patients into its ETS2101 Phase Ia solid tumors trial being conducted at three centers in the ...
Blowing smoke [Published PharmaGossip - Feb 20 2014]
Glaxo Memo Shows Drug Industry Lobbying on E-Cigarettes GlaxoSmithKline Plc (GSK)  is pushing for more stringent regulation of electronic cigarettes, which compete with its  Nicorette  gum and other smoking cessation products, according to e-mails from ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.